Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAnkara City Hospital Bilkent
About this trial
In this study, it was aimed to compare the effect of subcutaneous lidocaine injection, which is routinely applied in pain clinic,in patients who present with pain complaints due to acute herpes zoster and post-herpetic neuralgia, and investigate its contribution to preventing the development of post-herpetic neuralgia
Eligibility criteria
Qualifiers
patients over the age of 18
with acute HZ pain (rash duration < 30 days
pain due to PHN (rash duration > 3 months),
Disqualifiers
None
Trial design
Treatments tested in this trial
- Lidocaine (drug)
Treatment groups
76 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov